Melatonin attenuates renal ischemia-reperfusion injury in nitric oxide synthase inhibited rats

Acta Histochemica

Volumn 108, Issue 4, 2006, Pages 303-309

  Deniz, Esra ^a   Colakoglu, Neriman ^a   Sari, Aysel ^a   Sonmez, Mehmet Fatih ^a   Tugrul, Ibrahim ^a   Oktar, Suleyman ^a   Ilhan, Selcuk ^a   Sahna, Engin ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Hypertension; Ischemia reperfusion; Kidney; l NAME; Malondialdehyde; Melatonin

Indexed keywords

BIOLOGICAL ORGANS; DISEASE CONTROL; LIPIDS; LIVING SYSTEMS STUDIES; MEDICAL PROBLEMS; METABOLITES;

HYPERTENSION; ISCHEMIA REPERFUSION; KIDNEY; L-NAME; MALONDIALDEHYDE; MELATONIN; NITRIC OXIDE SYNTHASE;

ENZYME INHIBITION;

FREE RADICAL; MALONALDEHYDE; MELATONIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE FLUCTUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; KIDNEY BLOOD VESSEL; KIDNEY ISCHEMIA; LIPID PEROXIDATION; MALE; NEPHRECTOMY; NONHUMAN; RAT; RENOVASCULAR HYPERTENSION; REPERFUSION; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

EID: 33749553138     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2006.04.002     Document Type: Article

References (33)

1. Babal P., Pechanova O., Bernatova I., and Stvrtina S. Chronic inhibition of NO synthesis produces myocardial fibrosis and vascular medial hyperplasia. Histol Histopathol 12 (1997) 623-629
2. Balaszczuk A.M., Tomat A., Bellucci S., Fellet A., and Arranz C. Nitric oxide synthase blockade and body fluid volumes. Braz J Med Biol Res 35 (2002) 131-134
3. Bird J.E., Milhoan K., Wilson C.B., Young S.G., Mundy C.A., Parthasarathy S., et al. Ischemic acute renal failure and antioxidant therapy in the rat: the relation between glomerular and tubular dysfunction. J Clin Invest 81 (1988) 1630-1638
4. Chintala M.S., Chiu P.J., Vemulapalli S., Watkins R.W., and Sybertz E.J. Inhibition of endothelium derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn-Schmiedeberg's Arch Pharmacol 348 (1993) 305-310
5. Gauhier T.W., Davenpeck K.L., and Lefer A.M. Nitric oxide attenuates leucocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 267 (1994) 562
6. Husain K. Interaction of exercise training and chronic NOS inhibition on blood pressure, heart rate, NO and antioxidants in plasma of rats. Pathophysiology 10 (2003) 47-56
7. Laflammer K., Wu S., Foucart A.L., and Champlain D.J. Impaired basal sympathetic tone and alpha-1 adrenergic responses in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 11 (1998) 219-229
8. Paller M.S., Hoidal J., and Ferris T.F. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74 (1984) 1156
9. Peer G., Blum M., and Laina A. Nitric oxide and acute renal failure. Nephron 73 (1996) 375-381
10. Pieri C., Marra M., Moroni F., Rechionni R., and Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55 (1994) 271-276
11. Reiter R.J., and Tan D.X. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58 (2003) 10-19
12. Reiter R.J., Tan D.X., Osuna C., and Gitto L. Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 7 (2001) 444-458
13. Reiter R.J., Tan D.X., Gitto E., Sainz R.M., Juan C.M., Josefa L., et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol J Pharmacol 56 (2004) 159-170
14. Rhoden E.L., Rhoden C.R., Lucas M.L., Pereira-Lima L., Zettler C., and Bello-Klein A. The role of nitric oxide pathway in the renal ischemia-reperfusion injury in rats. Transplant Immunol 10 (2002) 277-284
15. Ribeiro M.O., Antunes E., De-Nucci G., Lovisolo S.M., and Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20 (1992) 298-303
16. Rodriguez-Reynoso S., Leal C., Portilla E., Olivares N., and Muniz J. Effect of exogenous melatonin on hepatic energetic status during ischemia-reperfusion: possible role of TNF-α and nitric oxide. J Surg Res 100 (2001) 141
17. Rodriguez-Reynoso S., Leal C., Portilla-de Buen E., Castillo J.C., and Ramos-Solano F. Melatonin ameliorates renal ischemia/reperfusion injury. J Surg Res 116 (2004) 242-247
18. Sahna E., Parlakpinar H., Ozturk F., Cigremis Y., and Acet A. The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res 31 (2003) 188-193
19. Sahna E, Parlakpinar H, Cihan OF, Turkoz Y, Acet A. Effects of aminoguanidine against renal ischaemia-reperfusion injury in rats. Cell Biochem Funct. 2004, 2006; 24:137-41.
20. Sahna E., Parlakpinar H., Türköz Y., and Acet A. Effects of melatonin on myocardial ischemia-reperfusion-induced infarct size and oxidative stress. Physiol Res 54 (2005) 491-495
21. Saito M., and Miyagawa I. Real-time monitoring of nitric oxide in ischemia-reperfusion rat kidney. Urol Res 28 (2000) 141-146
22. Sanchez-Perez-Verdia E., Lopez-Neblina F., Portilla E., Ortiz G.G., Gonzalez-Ojeda A., and Alvares R. Exogenous nitric oxide protects kidney from ischemia/reperfusion. J Invest Surg 14 (2001) 313-320
23. Sener G., Sehirli A.O., Keyer-Uysal M., Arbak S., Ersoy Y., and Yegen B.C. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat. J Pineal Res 32 (2002) 120-126
24. Sewerynek E. Melatonin and the cardiovascular system. Neuro Endocrinol Lett 23 Suppl 1 (2002) 79-83
25. Shoskes D.A., Xie Y., and Gonzalez-Cadavid N.F. Nitric oxide synthase activity in renal ischemia-reperfusion in the rat: implications for renal transplantation. Transplantation 63 (1997) 495-500
26. Touyz R.M., and Schiffrin E.L. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122 (2004) 339-352
27. Tsaknis J., Lalas S., Hole M., Smith G., and Tychopoulos V. Rapid high-performance liquid chromatographic method of determining malondialdehyde for evaluation of rancidity in edible oils. Analyst 123 (1998) 325-327
28. Unal D., Yeni E., Erel O., Bitiren M., and Vural H. Antioxidative effects of exogenous nitric oxide versus antioxidant vitamins on renal ischemia reperfusion injury. Urol Res 30 (2002) 190-194
29. Walker L.M., Walker P.D., Imam S.Z., Ali S.F., and Mayeux P.R. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor l-N (6)-(1-Iminoethyl) lysine. J Pharmacol Exp Ther 295 (2000) 417-422
30. Waz W.R., Van Liew J.B., and Feld L.G. Nitric oxide metabolism following unilateral renal ischemia-reperfusion injury in rats. Pediatr Nephrol 12 (1998) 26-29
31. Weinberg J.M. The cell biology of ischemic renal injury. Kidney Int 39 (1991) 476-500
32. Wojcicka G., Beltowski J., and Jamroz A. Oxidative stress in hypertension. Postepy Hig Med Dosw 58 (2004) 183-193
33. Wright C.E., Rees D.D., and Moncada S. Protective and pathological roles of nitric oxide in endotoxic shock. Cardiovasc Res 26 (1992) 48